with hyperthyroidism. J Feline Med Surg 16:491–498.720 Van Ginkel, R.J., H.J. Hoekstra, F.J. Meutstege, et al. 1995. Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: Assessment of short‐term effects. J Surg Oncol 59:169–176.
721 Van Lelyveld, S., J. Warland, R. Miller, et al. 2015. Comparison between Ki‐67 index and mitotic index for predicting outcome in canine mast cell tumours. J Small Anim Pract 56:312–319.
722 Vancil, J.M., C.J. Henry, R.J. Milner, et al. 2012. Use of samarium Sm 153 lexidronam for the treatment of dogs with primary tumors of the skull: 20 cases (1986–2006). J Am Vet Med Assoc 240:1310–1315.
723 Vasseur, P. 1987. Limb preservation in dogs with primary bone tumors. Vet Clin North Am Small Anim Pract 17:889–903.
724 Vaudaux, C., U. Schneider, and B. Kaser‐Hotz. 2007. Potential for intensity‐modulated radiation therapy to permit dose escalation for canine nasal cancer. Vet Radiol Ultrasound 48:475–481.
725 Venable, R.O., C.F. Saba, M.M. Endicott, et al. 2012. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs. J Am Vet Med Assoc 240:304–307.
726 Venzin, C., S. Grundmann, and P. Montavon. 2012. Endoprosthesis (EN) in frontlimb‐sparing surgery for distal radial tumours in the dog: Preliminary results. Schweiz Arch Tierheilkd 154:337–343.
727 Villalobos, A. 2006. Dealing with chemotherapy extravasations: A new technique. J Am Anim Hosp Assoc 42:321–325.
728 Vincenti, S. and F. Findji. 2017. Influence of treatment on the outcome of dogs with incompletely excised grade‐2 mast cell tumors. Schweiz Arch Tierheilkd 159:171–177.
729 Von Euler, H., A. Sadeghi, B. Carlsson, et al. 2008. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma. J Immunother 31:377–384.
730 Walker, M. and M. Breider. 1987. Intraoperative radiotherapy of canine bladder cancer. Vet Radiol 28:200–204.
731 Wallace, J., D.T. Matthiesen, and A.K. Patnaik. 1992. Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 21:337–341.
732 Walter, C.U., W.S. Dernell, S.M. Larue, et al. 2005. Curative‐intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: A preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol 3:1–7.
733 Waltman, S.S., B. Seguin, B.J. Cooper, et al. 2007. Clinical outcome of nonnasal chondrosarcoma in dogs: Thirty‐one cases (1986–2003). Vet Surg 36:266–271.
734 Wang, Z., W. Qiu, and W.M. Mendenhall. 2003. Influence of radiation therapy on reconstructive flaps after radical resection of head and neck cancer. Int J Oral Maxillofac Surg 32:35–38.
735 Ward, H., L.E. Fox, M.B. Calderwood‐Mays, et al. 1994. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 8:345–348.
736 Webster, J.D., V. Yuzbasiyan‐Gurkan, R.A. Miller, et al. 2007. Cellular proliferation in canine cutaneous mast cell tumors: Associations with c‐Kit and its role in prognostication. Vet Pathol 44:298–308.
737 Weisse, C. 2015. Veterinary interventional oncology: From concept to clinic. Vet J 205:198–203.
738 Weisse, C., A. Berent, K. Todd, et al. 2006. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc 229:226–234.
739 Weisse, C., C.A. Clifford, D. Holt, et al. 2002a. Percutaneous arterial embolization and chemoembolization for treatment of benign and malignant tumors in three dogs and a goat. J Am Vet Med Assoc 221:1430–1436, 1419.
740 Weisse, C., F.S. Shofer, and K. Sorenmo. 2002b. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38:71–73.
741 Weisse, C., N. Soares, M.W. Beal, et al. 2005. Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226:575–579.
742 Wells, A.L., C.D. Long, W.J. Hornof, et al. 2001. Use of percutaneous ethanol injection for treatment of bilateral hyperplastic thyroid nodules in cats. J Am Vet Med Assoc 218:1293–1297.
743 Wendelburg, K.M., L.L. Price, K.E. Burgess, et al. 2015. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247:393–403.
744 Westberg, S., A. Sadeghi, E. Svensson, et al. 2013. Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma. J Immunother 36:350–358.
745 White, R. 1991. Mandibulectomy and maxillectomy in the dog: Longterm survival in 100 cases. J Small Anim Pract 32:69–74.
746 White, R., M. Walker, A.M. Legendre, et al. 1990. Development of brachytherapy technique for nasal tumors in dogs. Am J Vet Res 51:1250–1256.
747 Wiley, J.L., K.A. Rook, C.A. Clifford, et al. 2010. Efficacy of doxorubicin‐based chemotherapy for non‐resectable canine subcutaneous haemangiosarcoma. Vet Comp Oncol 8:221–233.
748 Willard, M.D., H. Tvedten, R. Walshaw, et al. 1980. Thymoma in a cat. J Am Vet Med Assoc 176:451–453.
749 Williams, L.E., J.M. Gliatto, R.K. Dodge, et al. 2003. Carcinoma of the apocrine glands of the anal sac in dogs: 113 cases (1985–1995). J Am Vet Med Assoc 223:825–831.
750 Williams, L.E., J.L. Johnson, M.L. Hauck, et al. 2004. Chemotherapy followed by half‐body radiation therapy for canine lymphoma. J Vet Intern Med 18:703–709.
751 Williams, L.E., A.F. Pruitt, and D.E. Thrall. 2010. Chemotherapy followed by abdominal cavity irradiation for feline lymphoblastic lymphoma. Vet Radiol Ultrasound 51:681–687.
752 Wilson, H.M., R. Chun, V.S. Larson, et al. 2007. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990–2004). J Am Vet Med Assoc 231:101–106.
753 Withrow, S.J., E.L. Gillette, P.J. Hoopes, et al. 1989. Intraoperative irradiation of 16 spontaneously occurring canine neoplasms. Vet Surg 18:7–11.
754 Withrow, S.J., J.M. Liptak, R.C. Straw, et al. 2004. Biodegradable cisplatin polymer in limb‐sparing surgery for canine osteosarcoma. Ann Surg Oncol 11:705–713.
755 Withrow, S.J., D.E. Thrall, R.C. Straw, et al. 1993. Intra‐arterial cisplatin with or without radiation in limb‐sparing for canine osteosarcoma. Cancer 71:2484–2490.
756 Wood, C.A., A.S. Moore, J.M. Gliatto, et al. 1998. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991–1993). J Am Anim Hosp Assoc 34:417–421.
757 Worth, A.J., R.M. Zuber, and M. Hocking. 2005. Radioiodide (131I) therapy for the treatment of canine thyroid carcinoma. Aust Vet J 83:208–214.
758 Wouda, R.M., J. Borrego, N.S. Keuler, et al. 2016. Evaluation of adjuvant carboplatin chemotherapy in the management of surgically excised anal sac apocrine gland adenocarcinoma in dogs. Vet Comp Oncol 14:67–80.
759 Wouda, R.M., M.E. Miller, E. Chon, et al. 2015. Clinical effects of vinorelbine administration in the management of various
